WILLIAM WONG to Combined Modality Therapy
This is a "connection" page, showing publications WILLIAM WONG has written about Combined Modality Therapy.
Connection Strength
0.150
-
Cost-Effectiveness of Nivolumab in Recurrent Metastatic Head and Neck Squamous Cell Carcinoma. Oncologist. 2018 02; 23(2):225-233.
Score: 0.107
-
Angiosarcoma of the scalp and face: the Mayo Clinic experience. JAMA Otolaryngol Head Neck Surg. 2015 Apr; 141(4):335-40.
Score: 0.022
-
Outcomes in a multi-institutional cohort of patients treated with intraoperative radiation therapy for advanced or recurrent renal cell carcinoma. Int J Radiat Oncol Biol Phys. 2014 Mar 01; 88(3):618-23.
Score: 0.021